Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Overview of attention for article published in Molecular Cancer, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 6 patents
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 776 Dimensions

Readers on

mendeley: 725 Mendeley

Summary News X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,288 followers.

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4: lymphocyte activation gene-3 (LAG-3), T cell immunoglobulin and mucin-domain containing-3 (TIM-3), T cell immunoglobulin and ITIM domain (TIGIT), V-domain Ig suppresso…https://t.co/BtEmfJKZyJ

27 Jun 2020

Reply Repost Favourite

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. https://t.co/iT8LWggN9n

17 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.